Tryptophan

interferon alpha 1 ; Homo sapiens







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29099929 Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling. 2017 Dec 27 1
2 27436416 Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1. 2016 Jul 20 3
3 26096654 Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism. 2015 Jun 18 1
4 25346938 Disturbances of Tryptophan Metabolism and Risk of Depression in HCV Patients Treated with IFN-Alpha. 2014 Feb 25 5
5 20940053 Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C. 2011 Jan 1
6 21161299 Interferon-gamma (+874) T/A genotypes and risk of IFN-alpha-induced depression. 2011 Feb 1
7 19918244 CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. 2010 Apr 2
8 19853722 [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients]. 2009 Oct 3
9 18794514 Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders. 2008 Sep-Oct 1
10 18950381 Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status. 2008 Oct 1
11 17873497 Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects. 2007 5
12 15494706 IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. 2005 Jun 3
13 15956600 Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication. 2005 Jul 1
14 16142050 [Hepatitis C, interferon a and depression: main physiopathologic hypothesis]. 2005 May-Jun 2
15 16152734 Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. 2005 Aug 4
16 15153315 Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha. 2004 May 2
17 15449939 Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. 2004 Oct 5 1
18 12860366 Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients. 2003 Jul 15 1
19 14573318 Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. 2003 Nov 1 4
20 11799348 Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. 2002 Feb 4
21 12466036 The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. 2002 Dec 1
22 10982828 Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation. 2000 Oct 1
23 9376502 Study of mathematical model for product formation with recombinant microbes expressed IFN. 1997 2
24 8522205 Interferon induction of human tryptophanyl-tRNA synthetase safeguards the synthesis of tryptophan-rich immune-system proteins: a hypothesis. 1995 Nov 20 3
25 8471593 Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta. 1993 Apr 1
26 1369371 Improvement of recombinant gene expression in Escherichia coli for glucose-controlled continuous and fed-batch cultures. 1992 Jan 1
27 2463322 Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. 1989 Jan 4
28 2472288 Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. 1989 Jun 15 1
29 2428037 Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. 1986 Sep 1